Tyvyt (pyrotinib)

pyrotinib · Jiangsu Hengrui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tyvyt (pyrotinib), covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

See pricing